Feasibility of Cocooning Immunization Strategy With Influenza Vaccine

NACompletedINTERVENTIONAL
Enrollment

544

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Influenza
Interventions
BIOLOGICAL

Trivalent inactivated influenza vaccine

Intramuscular injection, 0.5 mL or 0.25 mL depending on age of vaccine recipient, one or two doses administered a month apart depending on age and prior influenza vaccination history of recipient

Trial Locations (2)

27704

Durham Regional Hospital, Durham

27710

Duke University Hospital, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

lead

Duke University

OTHER

NCT00570037 - Feasibility of Cocooning Immunization Strategy With Influenza Vaccine | Biotech Hunter | Biotech Hunter